GDGianluca D'Ippolito

Gianluca D'Ippolito

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gianluca D'Ippolito has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Paul C. Schiller

    2 shared publications
  • Andrea Bonnin-Marquez

    Geriatric Research, Education, and Critical limb ischemianical Center and Research Service, Bruce W. Carter VAMC, Miami, FL, USA

    1 shared publication
  • B.A Roos

    Stein Gerontological Institute, Miami, FL, USA

    1 shared publication
  • Bernard A. Roos

    Stein Gerontological Institute, Miami, FL 33137, USA

    1 shared publication
  • C Perez-Stable

    Geriatric Research, Education, and Clinical Center and Research Service, Veterans Affairs Medical Center, and Department of Medicine, University of Miami School of Medicine, Miami, FL, USA

    1 shared publication
  • Cristina Grau-Monge

    Department of Orthopaedics, University of Miami Miller School of Medicine, FL, United States of America. Geriatric Research, Education, and Clinical Center and Research Service, Bruce W. Carter VAMC, Miami, FL, United States of America

    1 shared publication

Latest Publications

  • Marrow-isolated adult multilineage inducible cells embedded within a biologically-inspired construct promote recovery in a mouse model of peripheral vascular disease

    by Cristina Grau-Monge, Gaëtan J-R Delcroix, Andrea Bonnin-Marquez, Mike Valdes, Ead Lewis Mazen Awadallah, Daniel F Quevedo, Maxime R Armour, Ramon B Montero, Paul C Schiller, Fotios M Andreopoulos, et al.

    Peripheral vascular disease is one of the major vascular complications in individuals suffering from diabetes and in the elderly that is associated with significant burden in terms of morbidity and mortality. Stem cell therapy is being tested as an attractive alternative to traditional surgery to prevent and treat this disorder. The goal of this study was to enhance the protective and reparative potential of marrow-isolated adult multilineage inducible (MIAMI) cells by incorporating them within a bio-inspired construct (BIC) made of two layers of gelatin B electrospun nanofibers. We hypothesized that the BIC would enhance MIAMI cell survival and engraftment, ultimately leading to a better functional recovery of the injured limb in our mouse model of critical limb ischemia compared to MIAMI cells used alone. Our study demonstrated that MIAMI cell-seeded BIC resulted in a wide range of positive outcomes with an almost full recovery of blood flow in the injured limb, thereby limiting the extent of ischemia and necrosis. Functional recovery was also the greatest when MIAMI cells were combined with BICs, compared to MIAMI cells alone or BICs in the absence of cells. Histology was performed 28 days after grafting the animals to explore the mechanisms at the source of these positive outcomes. We observed that our critical limb ischemia model induces an extensive loss of muscular fibers that are replaced by intermuscular adipose tissue (IMAT), together with a highly disorganized vascular structure. The use of MIAMI cells-seeded BIC prevented IMAT infiltration with some clear evidence of muscular fibers regeneration.


  • Adult and Embryonic Stem Cells in Cartilage Repair

    by Paul C. Schiller, Gianluca D'Ippolito

    Injured cartilage tissue has a limited capacity to heal. There is increasing need for the development of biologically based approaches for cartilage repair. The ultimate aim is to repair the damaged cartilage tissue with new functional tissue using living cells (alone or in combination with suitable scaffolds) that will integrate with the patients remaining tissue and yield a regenerated functional joint, which could continue to repair itself and maintain tissue homeostasis, and remain functional throughout the life of the patient. Cell therapy approaches represent a novel strategy in the treatment of cartilage diseases. Among the different types of stem/progenitor cells that are currently being evaluated, the benefits and limitations of approaches using embryonic and adult stem cells will ultimately depend on factors related to efficacy and safety. To achieve these goals a clear and profound understanding of the molecular determinants of chondrocyte differentiation and cartilage tissue formation is essential, including the specific effect of trophic factors guiding the chondrogenic differentiation process, their relationship with the tissue microenvironment, and how they translate to an epigenetically stable and homogeneous functional tissue. Despite the increasing progress in the application of human embryonic stem cells for cartilage repair, ethical and safety concerns (primarily teratoma and tumor formation) remain to be resolved. Adult stem cells have demonstrated the greatest promise and bone marrow-derived stromal cell subpopulations represent the most widely studied cell types. Developmentally immature marrow stromal cells have been isolated by several groups which appear capable of meeting most, if not all, of the criteria needed for a successful approach. Here we will review the use of embryonic and adult stem cells for cartilage tissue engineering.


  • Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells

    by Gianluca D'Ippolito, Sylma Diabira, Guy A. Howard, Bernard A. Roos, Paul C. Schiller